Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 1467 entries
View as:

Obese Patients With or Without Comorbidities (RIO-North America)

Phase: N/A Priority: Normal
NCT ID: NCT00029861 Org: User:
Start: 08/31/01 End: 04/30/04 Due: 04/30/05

Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

Phase: N/A Priority: Normal
NCT ID: NCT00995293 Org: User:
Start: 08/27/09 End: 01/26/18 Due: 01/26/19

Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT02332577 Org: User:
Start: 04/30/15 End: 02/20/23 Due: 02/20/24

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS

Phase: N/A Priority: Normal
NCT ID: NCT00232297 Org: User:
Start: 06/30/05 End: 02/28/07 Due: 02/28/08

Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient

Phase: N/A Priority: Normal
NCT ID: NCT01955629 Org: User:
Start: 12/31/13 End: 03/31/15 Due: 03/31/16

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT03687359 Org: User:
Start: 08/15/19 End: 04/21/36 Due: 04/21/37

Resection Observatory

Phase: N/A Priority: Normal
NCT ID: NCT05178745 Org: User:
Start: 09/07/16 End: 05/27/22 Due: 05/27/23

A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT00457249 Org: User:
Start: 03/31/07 End: 11/30/08 Due: 11/30/09

Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT00908921 Org: User:
Start: 04/30/09 End: 09/30/10 Due: 09/30/11

Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)

Phase: N/A Priority: Normal
NCT ID: NCT00627471 Org: User:
Start: 01/31/08 End: - Due: -

A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Phase: N/A Priority: Normal
NCT ID: NCT02536937 Org: User:
Start: 09/30/15 End: 01/31/17 Due: 01/31/18

Efficacy and Safety of Teicoplanin in CDAD

Phase: N/A Priority: Normal
NCT ID: NCT04003818 Org: User:
Start: 05/15/20 End: 03/10/21 Due: 03/10/22

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

Phase: N/A Priority: Normal
NCT ID: NCT01198873 Org: User:
Start: 09/30/10 End: 01/31/12 Due: 01/31/13

A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00952276 Org: User:
Start: 10/31/09 End: 03/31/11 Due: 03/31/12

Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)

Phase: N/A Priority: Normal
NCT ID: NCT00622115 Org: User:
Start: 07/31/07 End: 11/30/07 Due: 11/30/08

Effect of Cabazitaxel on the QTc Interval in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01087021 Org: User:
Start: 03/31/10 End: 11/30/11 Due: 11/30/12

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT05132569 Org: User:
Start: 12/03/21 End: 02/21/23 Due: 02/21/24

Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion

Phase: N/A Priority: Normal
NCT ID: NCT02603510 Org: User:
Start: 11/30/15 End: 04/30/16 Due: 04/30/17

START: Swiss Taxotere Alopecia Prevention Trial

Phase: N/A Priority: Normal
NCT ID: NCT01008774 Org: User:
Start: 07/31/09 End: 10/31/11 Due: 10/31/12

Extension to Study HMR1964A/3011 in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT00576862 Org: User:
Start: 11/30/02 End: 04/30/04 Due: 04/30/05

A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide

Phase: N/A Priority: Normal
NCT ID: NCT03387657 Org: User:
Start: 01/03/18 End: 03/02/18 Due: 03/02/19

Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT04940026 Org: User:
Start: 06/15/21 End: 08/19/21 Due: 08/19/22

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03546907 Org: User:
Start: 07/16/18 End: 02/21/20 Due: 02/21/21

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00254956 Org: User:
Start: 01/31/04 End: 06/30/05 Due: 06/30/06

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

Phase: N/A Priority: Normal
NCT ID: NCT05263193 Org: User:
Start: 06/08/22 End: 10/28/22 Due: 10/28/23